In phase II, the top 5 (AUC ranking) of the 31 overexpressed IgM autoantibodies were tested in a larger cohort comprising sera from 147 LUADs, 147 matched NCs, 72 LUSC patients, and 44 SCLC patients using indirect ELISA. This evidence concerns the gene CD40LG and small cell lung carcinoma.